Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control Study

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related disease (COVID-19) has spread pandemically with high rates of morbidity and mortality. COVID-19 has also posed unprecedented challenges in terms of rapid development of pharmacological countermeasures to prevent or contrast SARS-Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramirez, Giuseppe A., Gerosa, Maria, Bellocchi, Chiara, Arroyo-Sánchez, Daniel, Asperti, Chiara, Argolini, Lorenza M., Gallina, Gabriele, Cornalba, Martina, Scotti, Isabella, Suardi, Ilaria, Moroni, Luca, Beretta, Lorenzo, Bozzolo, Enrica P., Caporali, Roberto, Dagna, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527378/
https://www.ncbi.nlm.nih.gov/pubmed/37759674
http://dx.doi.org/10.3390/biom13091273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527378/
https://www.ncbi.nlm.nih.gov/pubmed/37759674
http://dx.doi.org/10.3390/biom13091273

Ejemplares similares